Julia Levy

580 total citations
23 papers, 453 citations indexed

About

Julia Levy is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Julia Levy has authored 23 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Immunology and 4 papers in Organic Chemistry. Recurrent topics in Julia Levy's work include Immunotherapy and Immune Responses (6 papers), Chemical Synthesis and Analysis (4 papers) and Immune Cell Function and Interaction (4 papers). Julia Levy is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Chemical Synthesis and Analysis (4 papers) and Immune Cell Function and Interaction (4 papers). Julia Levy collaborates with scholars based in Canada, United Kingdom and United States. Julia Levy's co-authors include Rodney L. Biltonen, Richard B. Whitney, G. Rialdi, Anajane G. Smith, Douglas G. Kilburn, Barbara Mitchell, David J. Granville, David W. C. Hunt, Alan G. Smith and Huijun Jiang and has published in prestigious journals such as The Journal of Immunology, JNCI Journal of the National Cancer Institute and Biochemistry.

In The Last Decade

Julia Levy

21 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Levy Canada 12 224 151 68 61 59 23 453
Malaya Bhattacharya United States 14 348 1.6× 149 1.0× 54 0.8× 22 0.4× 169 2.9× 31 598
Robert G. Parsons United States 13 245 1.1× 76 0.5× 73 1.1× 19 0.3× 57 1.0× 19 492
M. Szekerke Hungary 17 420 1.9× 83 0.5× 59 0.9× 26 0.4× 166 2.8× 42 639
Diane Neerunjun United Kingdom 7 430 1.9× 56 0.4× 73 1.1× 17 0.3× 113 1.9× 7 643
Wim P. Van Beek Netherlands 11 589 2.6× 162 1.1× 95 1.4× 23 0.4× 103 1.7× 15 758
Shigeru Nanno Japan 6 183 0.8× 63 0.4× 37 0.5× 40 0.7× 34 0.6× 14 345
Atsushi Tsuboi Japan 11 261 1.2× 40 0.3× 46 0.7× 34 0.6× 33 0.6× 26 490
Wim Jiskoot Netherlands 9 249 1.1× 260 1.7× 110 1.6× 29 0.5× 47 0.8× 9 482
Salvatore Pasquale Prete Italy 12 131 0.6× 212 1.4× 223 3.3× 26 0.4× 52 0.9× 30 412
Howard J. Glenn United States 12 143 0.6× 44 0.3× 106 1.6× 70 1.1× 252 4.3× 37 505

Countries citing papers authored by Julia Levy

Since Specialization
Citations

This map shows the geographic impact of Julia Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Levy more than expected).

Fields of papers citing papers by Julia Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Levy. The network helps show where Julia Levy may publish in the future.

Co-authorship network of co-authors of Julia Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Levy. A scholar is included among the top collaborators of Julia Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Levy. Julia Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kafatos, George, et al.. (2025). Leveraging Synthetic Data to Facilitate Research: A Collaborative Model for Analyzing Sensitive National Cancer Registry Data in England. Therapeutic Innovation & Regulatory Science. 59(5). 919–928.
2.
Kaufmann, Jens, Aaron M. Wieland, Lorenzo Alberio, et al.. (2023). OC 77.1 Development, Validation, and Implementation of a Decision Support Tool for the Screening of Mild Bleeding Disorders. Research and Practice in Thrombosis and Haemostasis. 7. 100381–100381.
3.
Carthy, Christopher M., David J. Granville, Huijun Jiang, et al.. (1999). Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-xL overexpression do not prevent early mitochondrial events but still depress caspase activity.. PubMed. 79(8). 953–65. 56 indexed citations
4.
Granville, David J., Julia Levy, & David W. C. Hunt. (1998). Photodynamic Treatment with Benzoporphyrin Derivative Monoacid Ring A Produces Protein Tyrosine Phosphorylation Events and DNA Fragmentation in Murine P815 Cells. Photochemistry and Photobiology. 67(3). 358–358. 2 indexed citations
5.
Weaver, Michael, et al.. (1988). Identification of a T cell subset using a rabbit antibody raised against a T suppressor molecule.. The Journal of Immunology. 141(7). 2268–2274. 1 indexed citations
6.
Malcolm, Andrew J., et al.. (1983). Partial characterization of a membrane antigen which exhibits specificity for cells of patients with acute myelogenous leukaemia. British Journal of Cancer. 47(6). 849–852. 2 indexed citations
7.
Kilburn, Douglas G., et al.. (1981). Helper cells active in the generation of cytotoxicity to a syngeneic tumor.. The Journal of Immunology. 127(4). 1394–1397. 15 indexed citations
8.
Levy, Julia, et al.. (1980). Isolation and partial characterization of a tumor-associated antigen of the P815 mastocytoma of DBA/2 mice.. The Journal of Immunology. 124(1). 143–150. 4 indexed citations
9.
Maier, T., Julia Levy, & Douglas G. Kilburn. (1980). The Lyt phenotype of cells involved in the cytotoxic response to syngeneic tumor and of tumor-specific suppressor cells. Cellular Immunology. 56(2). 392–399. 12 indexed citations
10.
Levy, Julia, et al.. (1979). The use of the enzyme-linked immunosorbent assay (ELISA) for the detection and quantification of specific antibody from cell cultures.. PubMed. 37(1). 45–52. 58 indexed citations
11.
Levy, Julia, Alan G. Smith, Richard B. Whitney, Robert McMaster, & Douglas G. Kilburn. (1976). Characterization of a T-lymphocyte inhibitor in the serum of tumour-bearing mice.. PubMed. 30(4). 565–73. 22 indexed citations
12.
Whitney, Richard B. & Julia Levy. (1975). Mode of Action of Immunosuppressive Substances in Sera of Tumor-Bearing Mice2. JNCI Journal of the National Cancer Institute. 55(6). 1447–1452. 9 indexed citations
13.
Whitney, Richard B., Julia Levy, & Anajane G. Smith. (1974). Influence of Tumor Size and Surgical Resection on Cell-Mediated Immunity in Mice2. JNCI Journal of the National Cancer Institute. 53(1). 111–116. 75 indexed citations
14.
Levy, Julia, G. Rialdi, & Rodney L. Biltonen. (1972). Thermodynamic studies of transfer ribonucleic acids. II. Characterization of the thermal unfolding of yeast phenylalanine-specific transfer ribonucleic acid. Biochemistry. 11(22). 4138–4144. 32 indexed citations
16.
Rialdi, G., Julia Levy, & Rodney L. Biltonen. (1972). Thermodynamic studies of transfer ribonucleic acids. I. Magnesium binding to yeast phenylalanine transfer ribonucleic acid. Biochemistry. 11(13). 2472–2479. 72 indexed citations
17.
Levy, Julia, et al.. (1971). Immunological studies on the major haptenic peptides from performic acid oxidized ferredoxin from Clostridium pasteurianum. Biochemistry. 10(10). 1763–1766. 16 indexed citations
19.
Mitchell, Barbara & Julia Levy. (1970). Immunological studies on peptides from the haptenic C-terminal octapeptide of Clostridium pasteurianum ferredoxin. Biochemistry. 9(14). 2762–2766. 13 indexed citations
20.
Mitchell, Barbara, et al.. (1970). Synthesis of haptenic C-terminal octapeptides of two cross-reacting bacterial ferredoxin molecules. Biochemistry. 9(8). 1839–1844. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026